Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.

Pastor-Idoate S, Rodriguez-Hernández I, Rojas J, Fernández I, García-Gutierrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y, Harsum S, Maclaren RE, Charteris D, van Meurs J, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group.

Ophthalmology. 2013 Mar;120(3):623-8. doi: 10.1016/j.ophtha.2012.08.019. Epub 2012 Dec 1.

PMID:
23207172
2.

The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.

Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutiérrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon Y, Harsum S, MacLaren RE, Charteris D, VanMeurs JC, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group.

PLoS One. 2013 Dec 9;8(12):e82283. doi: 10.1371/journal.pone.0082283. eCollection 2013.

3.

BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project.

Pastor-Idoate S, Rodríguez-Hernández I, Rojas J, Fernández I, García-Gutierrez MT, Ruiz-Moreno JM, Rocha-Sousa A, Ramkissoon YD, Harsum S, MacLaren RE, Charteris DG, Van Meurs JC, González-Sarmiento R, Pastor JC; Genetics on PVR Study Group.

Acta Ophthalmol. 2015 Nov;93(7):e541-9. doi: 10.1111/aos.12718. Epub 2015 May 19.

4.

Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study.

Sanabria Ruiz-Colmenares MR, Pastor Jimeno JC, Garrote Adrados JA, Telleria Orriols JJ, Yugueros Fernández MI.

Acta Ophthalmol Scand. 2006 Jun;84(3):309-13.

5.

A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy.

Rojas J, Fernandez I, Pastor JC, Maclaren RE, Ramkissoon Y, Harsum S, Charteris DG, Van Meurs JC, Amarakoon S, Ruiz-Moreno JM, Rocha-Sousa A, Brion M, Carracedo A; Genetics on PVR Study Group.

Invest Ophthalmol Vis Sci. 2013 Mar 5;54(3):1665-78. doi: 10.1167/iovs.12-10931.

PMID:
23258148
6.

p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.

Chen RH, Chang CT, Wang TY, Huang WL, Tsai CH, Tsai FJ.

J Clin Lab Anal. 2008;22(5):321-6. doi: 10.1002/jcla.20249.

PMID:
18803266
7.

The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian women.

Zubor P, Stanclova A, Kajo K, Hatok J, Klobusiakova D, Visnovsky J, Danko J.

Oncology. 2009;76(3):173-83. doi: 10.1159/000201570. Epub 2009 Feb 11.

PMID:
19209008
9.

P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.

Roh JW, Kim BK, Lee CH, Kim J, Chung HH, Kim JW, Park NH, Song YS, Park SY, Kang SB.

Oncol Res. 2010;18(9):453-9.

PMID:
20524403
10.

A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese.

Suzuki K, Matsui H, Ohtake N, Nakata S, Takei T, Nakazato H, Okugi H, Koike H, Ono Y, Ito K, Kurokawa K, Yamanaka H.

J Biomed Sci. 2003 Jul-Aug;10(4):430-5.

PMID:
12824702
11.

P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population.

Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wei Q.

Oncol Rep. 2004 May;11(5):1115-20.

PMID:
15069555
12.

Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.

Camelo-Santos J, do Prado Barbosa A, de Paula Silveira-Lacerda E, Guillo LA.

Biomed Pharmacother. 2013 Mar;67(2):103-7. doi: 10.1016/j.biopha.2012.11.004. Epub 2012 Nov 23.

PMID:
23433851
13.

Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population.

Omori S, Yoshida S, Kennedy SH, Negoro K, Hamana S, Barlow DH, Maruo T.

J Soc Gynecol Investig. 2004 May;11(4):232-6.

PMID:
15120697
14.

p53 codon 72 polymorphism and the risk of lung cancer in a Korean population.

Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yun WJ, Kim YC, Oh IJ, Kim KS, Shin MH.

Lung Cancer. 2011 Sep;73(3):264-7. doi: 10.1016/j.lungcan.2010.12.017. Epub 2011 Feb 11.

PMID:
21316118
15.

Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk.

Li MS, Liu JL, Wu Y, Wang P, Teng H.

Genet Mol Res. 2011 Nov 29;10(4):2924-33. doi: 10.4238/2011.November.29.3.

16.

[Association of p53 gene polymorphism with susceptibility to ovarian cancer].

Kang S, Duan LH, Zhang JH, Guo W, Wang N, Li Y.

Zhonghua Fu Chan Ke Za Zhi. 2004 Nov;39(11):754-8. Chinese.

PMID:
15634502
17.

p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.

Ji X, Neumann AS, Sturgis EM, Adler-Storthz K, Dahlstrom KR, Schiller JT, Wei Q, Li G.

Carcinogenesis. 2008 Apr;29(4):875-9. doi: 10.1093/carcin/bgn039. Epub 2008 Feb 6.

PMID:
18258602
18.

p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.

Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y.

Clin Cancer Res. 2005 Oct 15;11(20):7328-33.

19.

Primary open angle glaucoma was not found to be associated with p53 codon 72 polymorphism in a Brazilian cohort.

Silva RE, Arruda JT, Rodrigues FW, Moura KK.

Genet Mol Res. 2009;8(1):268-72.

PMID:
19291875
20.

Association of P53 codon 72 polymorphism and ameloblastoma.

Kitkumthorn N, Yanatatsaneejit P, Rabalert J, Dhammawipark C, Mutirangura A.

Oral Dis. 2010 Oct;16(7):631-5. doi: 10.1111/j.1601-0825.2010.01664.x.

PMID:
20412452

Supplemental Content

Support Center